发明名称 METHOD OF TREATING CERVICAL CANCER
摘要 FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely oncology, and can be used for treating cervical cancer. That is ensured by radiation teletherapy and brachytherapy. Each brachytherapy session is preceded by bringing the Hydrogel Coletex-M Tissue 3-5 ml to the tumour before 12-18 hours. Before gel contact, the Coletex-M Tissue is introduced. Further,1-1,5 hours prior to the brachytherapy session, the textile tissue is removed, and Hydrogel Coletex-ADL Tissue 4-6 ml is brought to the tumour. Preliminary, the Hydrogel Coletex-ADL Tissue is added with lidocaine to achieve the gel concentration 4-6%. ^ EFFECT: method provides reduced total toxicity and drug load ensured by the required concentration of metronidazole maintained in the tumour before the radiation session, and also analgesia without using narcotic preparations, optimised time and geometry of centring introduction that allows intensifying the damage exposure on the tumour. ^ 2 ex
申请公布号 RU2454256(C1) 申请公布日期 2012.06.27
申请号 RU20110116482 申请日期 2011.04.27
申请人 FGU "MOSKOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT IM. P.A. GERTSENA" MINISTERSTVA ZDRAVOOKHRANENIJA I SOTSIAL'NOGO RAZVITIJA ROSSIJSKOJ FEDERATSII;OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'JU "KOLETEKS";OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'JU "NPO TEKSTIL'PROGRESS INZHENERNOJ AKADEMII" 发明人 BOJKO ANNA VLADIMIROVNA;DEMIDOVA LJUDMILA VLADIMIROVNA;DUNAEVA ELENA ANATOL'EVNA;OLTARZHEVSKAJA NATAL'JA DMITRIEVNA;KOROVINA MARIJA ANATOL'EVNA;SHCHEL'TSYNA SVETLANA ANATOL'EVNA;KOROBKOVA ANNA JUR'EVNA
分类号 A61F13/02;A61K31/045;A61K31/10;A61K31/167;A61K31/417;A61K31/734;A61N5/10;A61P35/00;A61P43/00 主分类号 A61F13/02
代理机构 代理人
主权项
地址